Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Hi Tech Pharmacal Co Inc (HITK) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Hi Tech Pharmacal Co Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 887497.
Total stock buying since 2010: $0.
Total stock sales since 2010: $16,498,605.
Total stock option exercises since 2010: $6,634,105.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2013 | 0 | $0 | 119,216 | $5,075,950 | 302,385 | $4,274,064 |
2012 | 0 | $0 | 166,151 | $5,349,695 | 112,060 | $1,455,875 |
2011 | 0 | $0 | 0 | $0 | 193,845 | $755,656 |
2010 | 0 | $0 | 242,083 | $6,072,960 | 17,813 | $148,510 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2013-12 | 0 | $0 | 6,873 | $295,951 | 6,873 | $169,007 |
2013-10 | 0 | $0 | 93,718 | $4,041,074 | 145,718 | $2,234,846 |
2013-09 | 0 | $0 | 6,125 | $263,925 | 24,794 | $436,212 |
2013-02 | 0 | $0 | 4,639 | $176,282 | 4,639 | $49,544 |
2013-01 | 0 | $0 | 7,861 | $298,718 | 120,361 | $1,384,455 |
2012-12 | 0 | $0 | 5,626 | $199,385 | 5,626 | $89,397 |
2012-11 | 0 | $0 | 0 | $0 | 14,082 | $117,020 |
2012-10 | 0 | $0 | 84,250 | $2,771,680 | 14,671 | $119,224 |
2012-08 | 0 | $0 | 12,500 | $443,750 | 12,500 | $72,875 |
2012-07 | 0 | $0 | 63,775 | $1,934,880 | 65,181 | $1,057,359 |
2011-11 | 0 | $0 | 0 | $0 | 168,750 | $648,000 |
2011-10 | 0 | $0 | 0 | $0 | 25,095 | $107,656 |
2010-12 | 0 | $0 | 231,377 | $5,853,125 | 0 | $0 |
2010-10 | 0 | $0 | 1,000 | $21,220 | 4,802 | $41,243 |
2010-09 | 0 | $0 | 2,956 | $60,390 | 6,261 | $44,927 |
2010-07 | 0 | $0 | 6,750 | $138,225 | 6,750 | $62,340 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2013-12-13 | April Gary M (President, HCP Division) | Sale | 6,873 | 43.06 | 295,951 |
2013-12-13 | April Gary M (President, HCP Division) | Option Ex | 6,873 | 24.59 | 169,007 |
2013-10-10 | Seltzer Reuben (Vice Chairman, Business Dev't) | Sale | 11,250 | 43.13 | 485,212 |
2013-10-10 | Seltzer Reuben (Vice Chairman, Business Dev't) | Option Ex | 11,250 | 10.93 | 122,962 |
2013-10-09 | Seltzer David S (CEO, President, Sec'y, Treas.) | Option Ex | 75,000 | 14.99 | 1,124,250 |
2013-10-08 | Seltzer David S (CEO, President, Sec'y, Treas.) | Sale | 23,000 | 43.09 | 991,070 |
2013-10-04 | Goldwyn Martin M (Director) | Sale | 1,500 | 43.10 | 64,650 |
2013-10-04 | Goldwyn Martin M (Director) | Option Ex | 1,500 | 24.95 | 37,425 |
2013-10-03 | Peters William J (EVP & Chief Financial Officer) | Sale | 21,250 | 43.11 | 916,087 |
2013-10-03 | Peters William J (EVP & Chief Financial Officer) | Option Ex | 21,250 | 12.35 | 262,437 |
2013-10-02 | Simpson Bruce W (Director) | Sale | 10,100 | 43.14 | 435,714 |
2013-10-02 | Seltzer Reuben (Vice Chairman, Business Dev't) | Sale | 11,250 | 43.13 | 485,212 |
2013-10-02 | Seltzer Reuben (Vice Chairman, Business Dev't) | Option Ex | 11,250 | 13.50 | 151,875 |
2013-10-01 | Simpson Bruce W (Director) | Sale | 15,368 | 43.15 | 663,129 |
2013-10-01 | Simpson Bruce W (Director) | Option Ex | 25,468 | 21.04 | 535,897 |
2013-09-30 | April Gary M (President, HCP Division) | Sale | 3,125 | 43.08 | 134,625 |
2013-09-30 | April Gary M (President, HCP Division) | Option Ex | 3,125 | 32.59 | 101,843 |
2013-09-30 | Goldwyn Martin M (Director) | Option Ex | 3,111 | 13.50 | 41,998 |
2013-09-27 | Goldwyn Martin M (Director) | Sale | 3,000 | 43.10 | 129,300 |
2013-09-27 | Goldwyn Martin M (Director) | Option Ex | 7,308 | 19.23 | 140,496 |
2013-09-17 | Hirshaut Yashar (Director) | Option Ex | 11,250 | 13.50 | 151,875 |
2013-02-05 | Peters William J (VP and Chief Financial Officer) | Sale | 36 | 38.00 | 1,368 |
2013-02-05 | Peters William J (VP and Chief Financial Officer) | Option Ex | 36 | 10.68 | 384 |
2013-02-01 | Peters William J (VP and Chief Financial Officer) | Sale | 4,603 | 38.00 | 174,914 |
2013-02-01 | Peters William J (VP and Chief Financial Officer) | Option Ex | 4,603 | 10.68 | 49,160 |
2013-01-24 | Peters William J (VP and Chief Financial Officer) | Sale | 7,861 | 38.00 | 298,718 |
2013-01-24 | Peters William J (VP and Chief Financial Officer) | Option Ex | 7,861 | 10.68 | 83,955 |
2013-01-09 | Seltzer David S (CEO, President, Sec'y, Treas.) | Option Ex | 112,500 | 11.56 | 1,300,500 |
2012-12-10 | April Gary M (President, HCP Division) | Sale | 5,626 | 35.44 | 199,385 |
2012-12-10 | April Gary M (President, HCP Division) | Option Ex | 5,626 | 15.89 | 89,397 |
2012-11-14 | Goldwyn Martin M (Director) | Option Ex | 2,832 | 8.31 | 23,533 |
2012-11-05 | Hirshaut Yashar (Director) | Option Ex | 11,250 | 8.31 | 93,487 |
2012-10-16 | Van Hulst Jack (Director) | Sale | 3,000 | 32.75 | 98,250 |
2012-10-16 | Van Hulst Jack (Director) | Option Ex | 3,000 | 5.83 | 17,490 |
2012-10-16 | Goldwyn Martin M (Director) | Option Ex | 421 | 19.59 | 8,247 |
2012-10-16 | Seltzer Reuben (Vice Chairman, Business Dev't) | Sale | 6,800 | 32.56 | 221,408 |
2012-10-16 | Seltzer David S (CEO, President, Sec'y, Treas.) | Sale | 29,441 | 32.60 | 959,776 |
2012-10-15 | Seltzer Reuben (Vice Chairman, Business Dev't) | Sale | 3,200 | 33.47 | 107,104 |
2012-10-15 | Seltzer David S (CEO, President, Sec'y, Treas.) | Sale | 20,559 | 32.97 | 677,830 |
2012-10-12 | Seltzer Reuben (Vice Chairman, Business Dev't) | Sale | 11,250 | 33.01 | 371,362 |
2012-10-12 | Seltzer Reuben (Vice Chairman, Business Dev't) | Option Ex | 11,250 | 8.31 | 93,487 |
2012-10-11 | Seltzer Reuben (Vice Chairman, Business Dev't) | Sale | 10,000 | 33.59 | 335,950 |
2012-08-15 | Peters William J (VP and Chief Financial Officer) | Sale | 12,500 | 35.50 | 443,750 |
2012-08-15 | Peters William J (VP and Chief Financial Officer) | Option Ex | 12,500 | 5.83 | 72,875 |
2012-07-17 | Egbaria Kamel (Chief Scientific Officer, EVP) | Sale | 11,342 | 32.56 | 369,295 |
2012-07-17 | Egbaria Kamel (Chief Scientific Officer, EVP) | Option Ex | 11,342 | 23.10 | 262,000 |
2012-07-17 | April Gary M (President, HCP Division) | Sale | 10,624 | 32.41 | 344,323 |
2012-07-17 | April Gary M (President, HCP Division) | Option Ex | 10,624 | 21.94 | 233,122 |
2012-07-17 | Goldwyn Martin M (Director) | Sale | 401 | 32.05 | 12,852 |
2012-07-17 | Goldwyn Martin M (Director) | Option Ex | 401 | 14.99 | 6,010 |
2012-07-16 | Peters William J (VP and Chief Financial Officer) | Sale | 4,983 | 32.00 | 159,456 |
2012-07-16 | Peters William J (VP and Chief Financial Officer) | Option Ex | 4,983 | 19.95 | 99,410 |
2012-07-16 | Goldwyn Martin M (Director) | Sale | 5,956 | 30.97 | 184,457 |
2012-07-16 | Goldwyn Martin M (Director) | Option Ex | 5,956 | 14.24 | 84,843 |
2012-07-13 | April Gary M (President, HCP Division) | Sale | 10,000 | 29.35 | 293,470 |
2012-07-13 | April Gary M (President, HCP Division) | Option Ex | 10,000 | 9.06 | 90,630 |
2012-07-13 | Simpson Bruce W (Director) | Sale | 1,907 | 29.33 | 55,932 |
2012-07-13 | Simpson Bruce W (Director) | Option Ex | 1,907 | 19.59 | 37,358 |
2012-07-13 | Goldwyn Martin M (Director) | Option Ex | 1,406 | 8.31 | 11,683 |
2012-07-12 | Simpson Bruce W (Director) | Sale | 18,562 | 27.75 | 515,095 |
2012-07-12 | Simpson Bruce W (Director) | Option Ex | 18,562 | 12.52 | 232,303 |
2011-11-10 | Seltzer Reuben (Director) | Option Ex | 56,250 | 3.84 | 216,000 |
2011-11-10 | Seltzer David S (CEO, President, Sec'y, Treas.) | Option Ex | 112,500 | 3.84 | 432,000 |
2011-10-24 | Seltzer Reuben (Director) | Option Ex | 11,250 | 4.29 | 48,262 |
2011-10-10 | Goldwyn Martin M (Director) | Option Ex | 2,595 | 4.29 | 11,132 |
2011-10-06 | Hirshaut Yashar (Director) | Option Ex | 11,250 | 4.29 | 48,262 |
2010-12-13 | Deerfield Special Situations Fund International Ltd | Sale | 135,000 | 25.50 | 3,442,500 |
2010-12-10 | Deerfield Special Situations Fund International Ltd | Sale | 95,177 | 25.00 | 2,379,425 |
2010-12-09 | Deerfield Special Situations Fund International Ltd | Sale | 1,200 | 26.00 | 31,200 |
2010-10-06 | Goldwyn Martin M (Director) | Sale | 1,000 | 21.22 | 21,220 |
2010-10-06 | Goldwyn Martin M (Director) | Option Ex | 2,290 | 8.89 | 20,369 |
2010-10-05 | Goldwyn Martin M (Director) | Option Ex | 2,512 | 8.31 | 20,874 |
2010-09-21 | Goldwyn Martin M (Director) | Option Ex | 947 | 5.83 | 5,521 |
2010-09-20 | Goldwyn Martin M (Director) | Sale | 1,000 | 20.84 | 20,840 |
2010-09-20 | Goldwyn Martin M (Director) | Option Ex | 1,000 | 13.50 | 13,500 |
2010-09-16 | Goldwyn Martin M (Director) | Option Ex | 2,358 | 1.92 | 4,527 |
2010-09-13 | Goldwyn Martin M (Director) | Sale | 1,956 | 20.22 | 39,550 |
2010-09-13 | Goldwyn Martin M (Director) | Option Ex | 1,956 | 10.93 | 21,379 |
2010-07-16 | Harvey Bryce M (Officer) | Sale | 3,750 | 20.49 | 76,845 |
2010-07-16 | Harvey Bryce M (Officer) | Option Ex | 3,750 | 7.88 | 29,550 |
2010-07-16 | Goldwyn Martin M (Director) | Sale | 3,000 | 20.46 | 61,380 |
2010-07-16 | Goldwyn Martin M (Director) | Option Ex | 3,000 | 10.93 | 32,790 |
Insider trading activities including stock purchases, stock sales, and option exercises of HITK listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Hi Tech Pharmacal Co Inc (symbol HITK, CIK number 887497) see the Securities and Exchange Commission (SEC) website.